TIMP3 and neoplasm: Chen et al. discovered that miR-21 directly targets metalloproteinase 3 (TIMP3), which is overexpressed in RCC and acts as a tumor oncogene by promoting cancer cell proliferation and invasion (Chen et al., 2017).